CVEvulnerability

CVE-2026-21974

5.3 MEDIUM Published 2026-01-20 Modified 2026-06-17 Official page ↗
Status
Analyzed
Published
2026-01-20
Last modified
2026-06-17
Assigner
[email protected]
CVSS 3.1 ([email protected])
5.3 MEDIUM — CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N
Weaknesses
CWE-200

Description

Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 5.3 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N).

Affected configurations

• oracle life sciences central designer 7.0.1.0

Related

Weakness · CWE (1)

  • CWE-200 Exposure of Sensitive Information to an Unauthorized Actor weakness

References